Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Capecitabine Pill
Sponsor: University of Alabama at Birmingham